Intellia Therapeutics General Counsel James Basta receives $15M in 2021
Intellia Therapeutics reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Intellia Therapeutics reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, five executives at Intellia Therapeutics received on average a compensation package of $7.5M, a 237% increase compared to previous year.
Average pay of disclosed executives at Intellia Therapeutics
James Basta, General Counsel, received $15M in total. 97% of Basta's compensation, or $15M, was in option awards. Basta also received $235K in bonus, $220K in salary, as well as $5.4K in other compensation.
John M. Leonard, Chief Executive Officer, received a compensation package of $9.8M, which increased by 169% compared to previous year. 70% of the compensation package, or $6.9M, was in option awards.
Laura Sepp-Lorenzino, Chief Scientific Officer, earned $4.6M in 2021, a 171% increase compared to previous year.
David Lebwohl, Chief Medical Officer, received $4.3M in 2021, which increases by 105% compared to 2020.
Glenn G. Goddard, Chief Financial Officer, earned $4.1M in 2021, a 159% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 2, 2022.